Shanghai, China

Xiao-Yong Fan

This inventor holds 1 USPTO granted patent. Top assignees: Fudan University, Id Pharma Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiao-Yong Fan. Retrieved from https://idiyas.com/inventor/xiao-yong-fan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Inventor Xiao-Yong Fan

Introduction

Xiao-Yong Fan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of vaccine development, particularly through his innovative approaches to using viral vectors.

Latest Patents

One of his notable patents is titled "Anti-vaccine using Sendai virus as vector." This patent describes a recombinant Sendai virus vector vaccine that expresses immunodominant antigens. It can be utilized as both a therapeutic and preventive vaccine against tuberculosis. This innovative approach highlights his commitment to addressing critical health challenges.

Career Highlights

Xiao-Yong Fan has worked with esteemed institutions such as Fudan University and Id Pharma Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

He has collaborated with notable colleagues, including Tsugumine Shu and Zhi-Dong Hu. These partnerships have further enriched his research endeavors and expanded the impact of his work.

Conclusion

Xiao-Yong Fan's contributions to vaccine development and his innovative use of viral vectors demonstrate his dedication to improving public health. His work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…